News Archives - Page 497 of 501

New treatment in sight for dry eye disease

Wednesday, April 24 2013 | 00 h 00 min | News

Topical anakinra (Kineret), an interleukin-1 receptor antagonist generally used to treat rheumatoid arthritis, may be effective in treating dry eye...

Two treatments are better than one

Monday, April 22 2013 | 00 h 00 min | News

Combining two treatments are effective in defeating certain inherited disorders that cause blindness In 2010, András Komáromy and colleagues at...

Gene switch

Sunday, April 21 2013 | 00 h 00 min | News

German researchers have discovered that genes controlling blood vessel growth in the retina of mice are “switched on” by the protein serum...

Genes linked to the development of AMD, but not to its treatment

Wednesday, April 17 2013 | 00 h 00 min | News

The four gene variants linked to the development of AMD do not influence how patients respond to treatment using Lucentis and Avastin The gene...

Focus shift from biochemistry to biomechanics in eye disease

Monday, April 15 2013 | 00 h 00 min | News

Research on vision loss has always focused heavily on biochemical processes However, two Swedish researchers are now stressing the importance of...

« Previous 1 … 495 496 497 498 499 … 501 Next »

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Category: News

New treatment in sight for dry eye disease

Two treatments are better than one

Gene switch

Genes linked to the development of AMD, but not to its treatment

Focus shift from biochemistry to biomechanics in eye disease

Featured Posts

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025